Skip to content
BioBuzz
Primary Menu
  • Jobseekers
    • Career Resources
      • New to Biotech?
      • Biomanufacturing Jobs in Maryland
    • Job Board
    • Featured Employers
      • American Gene Technologies
      • BioFactura
      • Kite
      • NextCure
  • Employers
    • Employer Resources & Insights
    • Employer Solutions
      • Job Board
      • Recruiting Services
    • Post a Job
    • Workforce Development (Beta)
  • News
    • Newsletter
    • Featured
    • Weekly Quick Hits
    • Capital Projects
    • Press Releases
    • Submit Your Press Release
  • Features
    • 5 Questions With…
    • In Conversation
    • Guest Posts
    • People On The Move
    • Submit Your People On The Move
    • Be Featured
  • Hubs
    • BioHealth Capital Region Hub
      • Quick Hits BHCR
    • Greater Philly Region Hub
      • Quick Hits Philly
    • Research Triangle Park Region Hub
      • Quick Hits RTP
  • Events
    • Free Event Listing
    • BioBuzz Awards
      • 3rd Annual BioBuzz Awards Celebration & Symposium
      • 2022 Awards Winners
        • 2022 Awards Finalists
      • 2021 Awards Winners
      • 2020 Awards Winners
  • Newsletter Subscribe

Hepion’s Phase II NASH Study Hits Primary and Secondary Endpoints

Published on : May 23, 2023May 23, 2023 Published by : Mark Terry

Hepion’s Phase II NASH Study Hits Primary and Secondary Endpoints By Mark TerryMay 23, 2024 Non-alcoholic steatohepatitis (NASH) has been a very tough nut to crack, with numerous companies’ compounds [….]

Tagged in : FDA Hepion Pharmaceuticals HepQuant NAFLD NASH Non-alcoholic steatohepatitis
Categorized in : Newsletter Philadelphia News
View All Jobs Post a Job

Annual Sponsors

Bio-Trac
CRB
  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

CONTACT US ABOUT US

Terms & Conditions  Privacy Policy
Made with ♥ in Baltimore

© 2023 BioBuzz Media™